Everett Cunningham Exact Sciences Corp (EXAS) insider trading activity

Everett Cunningham is Chief Commercial Officer of EXACT SCIENCES CORP. Currently has a direct ownership of 47,042 shares of EXAS, which is worth approximately $2.73 Million. The most recent transaction as insider was on May 01, 2024, when has been sold 136 shares (Common Stock) at a price of $60.15 per share, resulting in proceeds of $8,180. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47K

0% 3M change

24.09% 12M change

Total Value Held $2.73 Million

Everett Cunningham Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 01 2024	SELL Open market or private sale	$8,180 $60.15 p/Share	136 Reduced 0.29%	47,042 Common Stock
Apr 30 2024	BUY Grant, award, or other acquisition	$14,994 $15.01 p/Share	999 Added 2.07%	47,178 Common Stock
Mar 01 2024	SELL Open market or private sale	$143,079 $59.32 p/Share	2,412 Reduced 4.96%	46,179 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	-	5,291 Added 9.82%	48,591 Common Stock
Feb 27 2024	SELL Open market or private sale	$207,534 $56.89 p/Share	3,648 Reduced 7.77%	43,300 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	-	7,678 Added 14.06%	46,948 Common Stock
Feb 22 2024	SELL Open market or private sale	$80,703 $59.78 p/Share	1,350 Reduced 3.32%	39,270 Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	2,711 Added 6.26%	40,620 Common Stock
Oct 12 2023	SELL Open market or private sale	$864,835 $66.49 p/Share	13,007 Reduced 25.55%	37,909 Common Stock
Oct 11 2023	BUY Exercise of conversion of derivative security	-	27,504 Added 35.07%	50,916 Common Stock
May 01 2023	BUY Grant, award, or other acquisition	$21,284 $30.02 p/Share	709 Added 2.94%	23,412 Common Stock
Mar 01 2023	SELL Open market or private sale	$224,972 $62.01 p/Share	3,628 Reduced 13.78%	22,703 Common Stock
Feb 27 2023	BUY Exercise of conversion of derivative security	-	7,677 Added 22.57%	26,331 Common Stock
Oct 12 2022	SELL Open market or private sale	$529,275 $31.37 p/Share	16,872 Reduced 47.49%	18,654 Common Stock
Oct 11 2022	BUY Exercise of conversion of derivative security	-	35,006 Added 49.63%	35,526 Common Stock
May 02 2022	BUY Grant, award, or other acquisition	$24,653 $47.41 p/Share	520 Added 50.0%	520 Common Stock

Also insider at

ARVN

ARVINAS, INC. Healthcare

Director

ILMN

ILLUMINA, INC. Healthcare

SVP, Chief Commercial Officer